Article
Bethesda, Md. - Replacing a patient's immune system with cancer-fighting cells can lead to the shrinkage of advanced melanoma tumors, researchers from the National Cancer Institute reported.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.